The ROE as of December 2025 (TTM) for Shanghai Shyndec Pharmaceutical Co., Ltd. (600420.SS) is 6.88%

According to Shanghai Shyndec Pharmaceutical Co., Ltd.’s latest financial reports and current stock price. The company's current ROE is 6.88%. This represents a change of 301.10% compared to the average of 1.72% of the last 4 quarters.

Shanghai Shyndec Pharmaceutical Co., Ltd. (600420.SS) Historical ROE (quarterly & annually)

How has 600420.SS ROE performed in the past?

The mean historical ROE of Shanghai Shyndec Pharmaceutical Co., Ltd. over the last ten years is 11.01%. The current 6.88% ROE has changed -37.47% with respect to the historical average. Over the past ten years (40 quarters), 600420.SS's ROE was at its highest in in the March 2016 quarter at 7.53%. The ROE was at its lowest in in the December 2021 quarter at -0.74%.

Shanghai Shyndec Pharmaceutical Co., Ltd. (600420.SS) ROE by Quarter and Year

Discovering the peaks and valleys of Shanghai Shyndec Pharmaceutical Co., Ltd. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Shanghai Shyndec Pharmaceutical Co., Ltd. (600420.SS) Average ROE

How has 600420.SS ROE performed in the past?

The current ROE of Shanghai Shyndec Pharmaceutical Co., Ltd. (600420.SS) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Shanghai Shyndec Pharmaceutical Co., Ltd. (600420.SS) ROE vs. Peers

How is 600420.SS’s ROE compared to its peers?

Shanghai Shyndec Pharmaceutical Co., Ltd.’s ROE is less than Zhejiang Medicine Co., Ltd. (11.31%), less than Jiang Zhong Pharmaceutical Co.,Ltd (21.26%), less than Tibet Rhodiola Pharmaceutical Holding Co. (24.95%), less than Guobang Pharma Ltd. (10.70%), less than Henan Lingrui Pharmaceutical Co., Ltd. (25.19%), less than Zhejiang Hisun Pharmaceutical Co., Ltd. (6.48%), less than Zhejiang Jingxin Pharmaceutical Co., Ltd. (12.52%), less than Pacific Shuanglin Bio-pharmacy Co., Ltd. (7.03%), less than Mayinglong Pharmaceutical Group Co., Ltd. (13.63%), greater than CanSino Biologics Inc. (-2.87%),

Build a custom stock screener for Shanghai Shyndec Pharmaceutical Co., Ltd. (600420.SS) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Shanghai Shyndec Pharmaceutical Co., Ltd. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Shanghai Shyndec Pharmaceutical Co., Ltd. (600420.SS) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Shanghai Shyndec Pharmaceutical Co., Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.